VERTEX PHARMACEUTICALS INC / MA Other Non-current Assets 2009-2026 | VRTX
Beta
What is VERTEX PHARMACEUTICALS INC / MA's current other non-current assets?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual other non-current assets for 2025 was $1.24B, a 23.75% increase from 2024. VERTEX PHARMACEUTICALS INC / MA other non-current assets for the quarter ending March 31, 2026 was $1.26B.
What was VERTEX PHARMACEUTICALS INC / MA's other non-current assets in 2024?
VERTEX PHARMACEUTICALS INC / MA annual other non-current assets for 2024 was $999.3M, a 11.62% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's other non-current assets in 2023?
VERTEX PHARMACEUTICALS INC / MA annual other non-current assets for 2023 was $895.3M, a 118.58% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year other non-current assets CAGR?
VERTEX PHARMACEUTICALS INC / MA other non-current assets grew at a compound annual growth rate (CAGR) of 90.49% from FY2020 to FY2025, going from $49.3M to $1.24B over 5 years.
Other Non-current Assets History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+90.5%
FY2020
$49.3M
→
FY2025
$1.24B
0910111213141516171819202122232425
5 years selected
Other Non-current Assets History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.24B | +23.7% | 10-K |
| FY2024 | $999.3M | +11.6% | 10-K |
| FY2023 | $895.3M | +118.6% | 10-K |
| FY2022 | $409.6M | +269.7% | 10-K |
| FY2021 | $110.8M | +124.7% | 10-K |
| FY2020 | $49.3M | -28.9% | 10-K |
| FY2019 | $69.4M | +70.4% | 10-K |
| FY2018 | $40.7M | +48.7% | 10-K |
| FY2017 | $27.4M | +130.5% | 10-K |
| FY2016 | $11.9M | +71.9% | 10-K |
| FY2015 | $6.9M | +111.7% | 10-K |
| FY2014 | $3.3M | +27.4% | 10-K |
| FY2013 | $2.6M | -73.5% | 10-K |
| FY2012 | $9.7M | -14.2% | 10-K |
| FY2011 | $11.3M | -34.4% | 10-K |
| FY2010 | $17.2M | +55.2% | 10-K |
| FY2009 | $11.1M | - | 10-K |
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →